Cytotoxic activity of Guettarda pohliana Müll. Arg. (Rubiaceae)

Paulo R N de Oliveira1, Gláucio Testa, Rebeca P Medina

  • 1a Departamento de Química , Universidade Estadual de Maringá , Av. Colombo 5790 , 87020-900 , Maringá , Paraná , Brazil.

Natural Product Research
|February 8, 2013
PubMed

Insights

G. pohliana leaf and root extracts show potent cytotoxic activity against human cancer cells, particularly leukemia (K-562) and melanoma (UACC-62). Phytochemical analysis identified key iridoids in active root fractions.

Area of Science:

  • Pharmacology
  • Natural Products Chemistry
  • Cancer Research

Background:

  • G. pohliana is a plant with potential medicinal properties.
  • Cytotoxic agents are crucial for cancer treatment.
  • Understanding plant-derived compounds' anti-cancer effects is vital.

Purpose of the Study:

  • To evaluate the cytotoxic activity of G. pohliana extracts and fractions against various human cancer cell lines.
  • To identify bioactive compounds responsible for the observed cytotoxicity.

Main Methods:

  • Crude extracts and fractions from G. pohliana leaves and roots were prepared.
  • Cytotoxic activity was assessed against nine human cancer cell lines using GI₅₀ values.
  • Phytochemical analysis was performed on the most active fraction.

Main Results:

  • Hexane leaf fraction (HL) and ethyl acetate (EAR), chloroform (CR), and hydromethanolic (HMR) root fractions exhibited significant activity against K-562 cells (GI₅₀ < 1 μg mL⁻¹).
  • CR and HMR fractions also showed activity against UACC-62 melanoma cells.
  • Phytochemical analysis of the CR fraction identified iridoids: secoxyloganin, sweroside, and loganin.

Conclusions:

  • G. pohliana possesses potent cytotoxic compounds effective against leukemia and melanoma cell lines.
  • The identified iridoids may contribute to the observed anti-cancer activity.
  • Further research into G. pohliana's therapeutic potential is warranted.

Related Concept Videos